Dr. Jamie Renbarger Appointed New Section Chief of Hemtology/Oncology at Riley Hospital
It is a pleasure to announce the appointment of Dr. Jamie Renbarger as the new Section Chief of Hematology/Oncology at Riley Hospital for Children at Indiana University Health. Grants from Riley Children’s Foundation, the philanthropic arm of Riley Hospital for Children at IU Health, are providing significant support for Dr. Renbarger’s recruitment and the Pediatric Precision Genomics program that she leads.
Dr. Renbarger is a graduate of St. Louis University School of Medicine and completed a pediatric hematology/oncology fellowship at Baylor College of Medicine, Houston and a clinical pharmacology fellowship at Indiana University School of Medicine. She is the Nora Letzter Scholar in Pediatric Oncology and the Interim Director of the Indiana Institute for Personalized Medicine and was the Academic Section Chief of Hematology/Oncology.
Dr. Renbarger is an international leader in pediatric personalized medicine and pharmacogenomics and is leading the pediatric cancer IU Health Precision Genomics program and aligned research program at Riley. She has made significant contributions to the School of Medicine and the greater research and clinical communities as a physician, leader, researcher and teacher. In 2011, Dr. Renbarger was a recipient of a Presidential Early Career Award for Scientists and Engineers, the highest honor bestowed by the United States government on science and engineering professionals. Her research program has been well funded by NIH for over 10 years, including a prestigious pediatric and developmental pharmacology center grant (U54), the Indiana Center for Pediatric Pharmacology. She is also committed to teaching and mentorship and serves as the PI of a pediatric and developmental pharmacology T32. She is highly committed to continuing down the path to finding ways to optimize cancer therapy to improve outcomes for individual children, and looks forward to embracing this new challenge to put critical resources in place to empower talented personnel to drive a shared vision.
Dr. Renbarger has ambitious plans to further strengthen the academic foundation in pediatric hematology/oncology, and capitalize on this as the basis for providing high quality patient care as well as grow an outstanding program with a strong reputation for clinical excellence rich in research discovery.